Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Mobile App Improves Treatment Adherence Success in Patients, Groundbreaking Tech Study Finds

A groundbreaking tech study by Kaizenovate has found that chiropractic and physiotherapy patients were more likely to adhere to their prescribed treatment plans when using the Kanvas App, than patients who did not download the app. In multiple studies, treatment adherence success has been shown to improve patient outcomes. The introduction of this digital accountability partner will revolutionize musculoskeletal health.


News provided by

Kaizenovate

Feb 03, 2022, 10:05 ET

Share this article

Share toX

Share this article

Share toX

The Kanvas App
The Kanvas App

WASHINGTON, Feb. 3, 2022 /PRNewswire-PRWeb/ -- Healthcare providers have long struggled with patients not adhering to prescribed therapy which includes not attending scheduled clinic visits (no-show appointments range from 19 - 42%) or prematurely terminating treatment against the advice of their provider (self-discharge).

A first-of-its-kind study by Kaizenovate has proven that technology can step in to fill this gap, with digital health interventions like the newly developed Kanvas App significantly improving the treatment adherence success rate in chiropractic and physiotherapy patients.

In this rapidly evolving era of technology, the chiropractic industry has seen a shift in the way we engage our communities and help patients achieve optimal outcomes. Kaizenovate continues to look ahead on further advancing our platform to positively impact healthcare globally.

Post this

Improving healthcare through technology, Kaizenovate developed the Kanvas App to support patients in their adherence to chiropractic and physiotherapy treatment plans. In addition to providing scheduling requests and patients' specific home exercise video library, the platform promotes patient engagement through gamification, providing points every time a patient attends their visits, which can be redeemed for healthcare products and services designed to maximize patient outcomes.

"A patient's adherence to the recommendations of their healthcare provider is the primary determinant of treatment success, often critical when the prescribed healthcare treatment involves chiropractic and physiotherapy to treat acute, subacute, and chronic musculoskeletal pain," said Dr. Jay Greenstein, CEO of Kaizenovate.

"Historical evidence suggests that two-thirds of patients involved in treatment programs including physiotherapy are not adherent with their prescribed treatment plans. But now, we've proven that the use of a mobile app can have a transformative impact on adherence. Having created a digital accountability partner will significantly move the needle for musculoskeletal health".

Recently published by JMIR, the Kanvas App was the basis of the Kaizenovate study, which proved that it could drive significantly greater care plan adherence for those who utilized the app.

The study compared adherence to prescribed physical health treatment among more than 4,000 patients attending multiple chiropractic rehabilitation clinics who did and did not choose to adopt a mobile app to complement their treatment.

Patients who downloaded the mobile app exhibited greater rates of completing their prescribed therapy visits than patients who did not download the app.

For patients who self discharged from care, the Kanvas App users had greater adherence to the treatment plans, with an increase of kept prescribed visits at 70% more than those who did not download the app.

Chiropractic and physiotherapy treatments have had historically low patient adherence rates. Digital accountability will revolutionize the industry and elevate the success rate for patients and providers alike.

The full study is available at https://rehab.jmir.org/2021/4/e31213/#ref1
Interviews, comments, and images are available upon request.

About Kaizenovate

Kaizenovate is a consulting and technology company led by Dr. Jay Greenstein, which builds long-lasting mobile tech solutions for clients and the population at large. The company's mission is to improve healthcare through technology.

About the Kanvas App
The Kanvas App is a customized private practice app designed for patient engagement with their specific health care provider. The initial screen includes various tiles in which the patient can engage with the office. These tiles include contact us, about us, refer a friend, request an appointment, review us, and home exercise. In addition, a built-in gamification system, the rewards tile, was designed to reward the patient for attending their scheduled clinic appointments. This feature is Office of Inspector General compliant, offering an item as a reward valued at <US $15 once the patient completed 12 prescribed visits or was provider-discharged. This feature documents a running total of the number of clinic visits that the patient had attended. The feature is patient-directed, where they scan a QR code at the front desk of the clinic at every visit. When the patient reaches 12 prescribed visits or is provider-discharged, they are eligible for a reward.

Media Contact

Manal El Ayachi, Kaizenovate, 1 2677335770, [email protected]

Twitter, LinkedIn

SOURCE Kaizenovate

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.